Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

videos

Jennifer Amengual, MD, Columbia University
Videos
Choosing Treatment Options for Patients With R/R DLBCL Ineligible for CAR T-Cell Therapy
04/18/2023
At the 2023 Great Debates & Updates in Hematologic Malignancies in New York, New York, Jennifer Amengual, MD, discussed the process of choosing among non-CAR-T options for patients with recurrent aggressive lymphoma, particularly DLBCL.
At the 2023 Great Debates & Updates in Hematologic Malignancies in New York, New York, Jennifer Amengual, MD, discussed the process of choosing among non-CAR-T options for patients with recurrent aggressive lymphoma, particularly DLBCL.
At the 2023 Great Debates &...
04/18/2023
Oncology
John Leonard, MD, Weill Cornell Medicine
Videos
New Developments in First- and Second-Line Treatments for Patients With Aggressive DLBCL
06/24/2022
John Leonard, MD, discusses recent therapeutic developments for aggressive DLBCL in the first- and second-line treatment settings, highlighting recent data around pelotuzumab vedotin and CAR-T therapies.
John Leonard, MD, discusses recent therapeutic developments for aggressive DLBCL in the first- and second-line treatment settings, highlighting recent data around pelotuzumab vedotin and CAR-T therapies.
John Leonard, MD, discusses...
06/24/2022
Oncology
Tycel Phillips, MD
Videos
Treatment Approaches for Patients With Untreated and Relapsed MCL
05/23/2022
Tycel Phillips, MD, reviews standard therapies utilized for patients with MCL, including nonaggressive regimens and BTK inhibitor therapies.
Tycel Phillips, MD, reviews standard therapies utilized for patients with MCL, including nonaggressive regimens and BTK inhibitor therapies.
Tycel Phillips, MD, reviews...
05/23/2022
Oncology
Sarah Rutherford, MD, Weill Cornell Medicine
Videos
CAR-T Therapy vs Other Novel Agents for Third-Line Treatment of FL
05/22/2022
Sarah Rutherford, MD, debates why she believes CAR-T therapy is the preferred treatment for patients with early progressing FL after 2 lines of prior therapy.
Sarah Rutherford, MD, debates why she believes CAR-T therapy is the preferred treatment for patients with early progressing FL after 2 lines of prior therapy.
Sarah Rutherford, MD, debates...
05/22/2022
Oncology
Tremendous Advances in Myeloma for 2020
Videos
Tremendous Advances in Myeloma for 2020
06/16/2020
Joseph Mikhael, MD, talks about what attendees can expect from the myeloma session at this year's virtual Great Debates & Updates in Hematologic Malignancies.
Joseph Mikhael, MD, talks about what attendees can expect from the myeloma session at this year's virtual Great Debates & Updates in Hematologic Malignancies.
Joseph Mikhael, MD, talks about...
06/16/2020
Oncology
Elias Jabbour, MD, to Debate on Approaches for Treating Relapsed ALL
Videos
Elias Jabbour, MD, to Debate on Approaches for Treating Relapsed ALL
06/15/2020
Dr Jabbour will be presenting on the management of patients with Ph+ and Ph-like ALL and taking part in a debate on approaches for the treatment of patients with relapsed ALL.
Dr Jabbour will be presenting on the management of patients with Ph+ and Ph-like ALL and taking part in a debate on approaches for the treatment of patients with relapsed ALL.
Dr Jabbour will be presenting on...
06/15/2020
Oncology
Gail Roboz, MD, Hints at Topics in AML, ALL Being Debated and Addressed
Videos
Gail Roboz, MD, Hints at Topics in AML, ALL Being Debated and Addressed
06/14/2020
Dr Roboz gives attendees a taste of what's to come at this year's virtual Great Debates & Updates in Hematologic Malignancies.
Dr Roboz gives attendees a taste of what's to come at this year's virtual Great Debates & Updates in Hematologic Malignancies.
Dr Roboz gives attendees a taste...
06/14/2020
Oncology
Contemporary Topics in the Treatment of Hematologic Malignancies
Videos
Contemporary Topics in the Treatment of Hematologic Malignancies
06/13/2020
Agner Paner, MD, will address updates in supportive care for patients with multiple myeloma at the virtual 2020 Great Debates & Updates in Hematologic Malignancies.
Agner Paner, MD, will address updates in supportive care for patients with multiple myeloma at the virtual 2020 Great Debates & Updates in Hematologic Malignancies.
Agner Paner, MD, will address...
06/13/2020
Oncology
Treatment Approaches for Aggressive Myeloproliferative Neoplasms
Videos
Treatment Approaches for Aggressive Myeloproliferative Neoplasms
05/28/2020
Ruben Mesa, MD, FACP, explains current and emerging therapy options for patients with myeloproliferative neoplasms.
Ruben Mesa, MD, FACP, explains current and emerging therapy options for patients with myeloproliferative neoplasms.
Ruben Mesa, MD, FACP, explains...
05/28/2020
Oncology
Therapeutic Approaches for the Patient with Relapsed Myeloma
Videos
Therapeutic Approaches for the Patient with Relapsed Myeloma
05/12/2020
Keith Stewart, MD, ChB, discusses therapeutic approaches for patients with early relapse of MM.
Keith Stewart, MD, ChB, discusses therapeutic approaches for patients with early relapse of MM.
Keith Stewart, MD, ChB,...
05/12/2020
Oncology

Advertisement

About

At Great Debates and Updates in Hematologic Malignancies, nationally recognized thought leaders take opposing sides on clinical—and sometimes controversial—topics currently disrupting the practice of hematology and oncology.

Through comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately.

Platinum Sponsors

johnson & johnson

 

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use